Dr Alexander Romanov (State Research Institute of Circulation Pathology) discusses the RAS trial that investigates radiofrequency (RF) ablation versus medical therapy for symptomatic frequent ventricular premature complexes as a first-line therapy in paediatric populations.

Filmed on site at EHRA 2019 by Radcliffe Cardiology

Questions:

1. What is aim of this study?

2. How was the ablation procedure conducted?

3. What were your results?

4. What are the key implications for practice?

Videographer: Tom Green/Mike Knight/Tom Brown
Interviewer: Mirjam Boros